JP2023512824A5 - - Google Patents
Info
- Publication number
- JP2023512824A5 JP2023512824A5 JP2022548118A JP2022548118A JP2023512824A5 JP 2023512824 A5 JP2023512824 A5 JP 2023512824A5 JP 2022548118 A JP2022548118 A JP 2022548118A JP 2022548118 A JP2022548118 A JP 2022548118A JP 2023512824 A5 JP2023512824 A5 JP 2023512824A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- protein
- acid sequence
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062971555P | 2020-02-07 | 2020-02-07 | |
| US62/971,555 | 2020-02-07 | ||
| PCT/US2021/016720 WO2021158854A2 (en) | 2020-02-07 | 2021-02-05 | Large gene vectors and delivery and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512824A JP2023512824A (ja) | 2023-03-29 |
| JP2023512824A5 true JP2023512824A5 (cg-RX-API-DMAC7.html) | 2024-02-14 |
| JP7846626B2 JP7846626B2 (ja) | 2026-04-15 |
Family
ID=77200426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548118A Active JP7846626B2 (ja) | 2020-02-07 | 2021-02-05 | 大型遺伝子ベクターならびにその送達および使用の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230090778A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4100518A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7846626B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220139924A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021216410A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022015601A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170709A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021158854A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL325122A (en) | 2018-02-22 | 2026-02-01 | Akouos Inc | Compositions and methods for treating non-age-related hearing impairment in humans |
| JP2021530227A (ja) | 2018-07-13 | 2021-11-11 | アコーオス インコーポレイテッド | 非症候性感音性聴力喪失の治療方法 |
| US12667628B2 (en) | 2019-07-03 | 2026-06-30 | Children's Medical Center Corporation | Compositions and methods for gene replacement |
| CA3168055A1 (en) | 2020-02-21 | 2021-08-26 | Emmanuel John Simons | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| US20240352086A1 (en) * | 2021-08-24 | 2024-10-24 | The Regents Of The University Of California | Compositions and methods comprising lipid associated transmembrane domains |
| CN116836975A (zh) * | 2022-03-25 | 2023-10-03 | 上海玮美基因科技有限责任公司 | 一种耳蜗和/或前庭细胞特异性启动子及其应用 |
| CN117106824B (zh) * | 2022-05-17 | 2025-09-02 | 上海佑音医药生物科技有限公司 | 一种治疗听力损伤的双载体系统及其应用 |
| EP4724470A1 (en) | 2023-06-12 | 2026-04-15 | Children's Hospital Medical Center | Aav-cftr vectors and methods of using same |
| CN116925239B (zh) * | 2023-07-17 | 2024-10-18 | 苏州星奥拓维生物技术有限公司 | 双载体系统表达Otof基因的组合物和方法 |
| CN118308390A (zh) * | 2024-04-24 | 2024-07-09 | 广州派真生物技术有限公司 | 一种内含肽联用载体及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002046208A2 (en) * | 2000-11-01 | 2002-06-13 | Elusys Therapeutics, Inc. | Method of producing biospecific molecules by protein trans-splicing |
| CN101595228A (zh) * | 2005-07-21 | 2009-12-02 | 艾博特公司 | 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法 |
| JP2013509188A (ja) * | 2009-10-30 | 2013-03-14 | アボット・ラボラトリーズ | Sorf構築物および複数の遺伝子発現 |
| JP6177780B2 (ja) * | 2011-09-28 | 2017-08-09 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | スプリットインテインおよびその使用 |
| CA2979120A1 (en) | 2015-03-03 | 2016-09-09 | Fondazione Telethon | Multiple aav vector system for expressing genes over 5 kilobases, comprising at least one degradation signal and uses thereof |
| WO2017209280A1 (ja) * | 2016-06-03 | 2017-12-07 | 国立大学法人鹿児島大学 | 酵母と断片化cDNAライブラリーを用いたタンパク質の新しい同定法 |
| KR20240007715A (ko) * | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| MA47820A (fr) * | 2017-03-10 | 2020-01-15 | Genethon | Traitement de la glycogénose de type iii |
| WO2018226602A1 (en) * | 2017-06-05 | 2018-12-13 | Research Institute At Nationwide Children's Hospital | Enhanced modified viral capsid proteins |
| JP2021530227A (ja) * | 2018-07-13 | 2021-11-11 | アコーオス インコーポレイテッド | 非症候性感音性聴力喪失の治療方法 |
| CA3116606A1 (en) | 2018-10-15 | 2020-04-23 | Fondazione Telethon | Intein proteins and uses thereof |
-
2021
- 2021-02-05 US US17/798,009 patent/US20230090778A1/en active Pending
- 2021-02-05 CA CA3170709A patent/CA3170709A1/en active Pending
- 2021-02-05 BR BR112022015601A patent/BR112022015601A2/pt unknown
- 2021-02-05 AU AU2021216410A patent/AU2021216410A1/en active Pending
- 2021-02-05 JP JP2022548118A patent/JP7846626B2/ja active Active
- 2021-02-05 KR KR1020227030657A patent/KR20220139924A/ko active Pending
- 2021-02-05 WO PCT/US2021/016720 patent/WO2021158854A2/en not_active Ceased
- 2021-02-05 EP EP21751290.4A patent/EP4100518A4/en active Pending